Merck, known as MSD outside the United States and Canada, announced today that the New Drug Application for SAFLUTAN, Merck’s investigational preservative-free prostaglandin analogue ophthalmic solution, has been accepted for standard review by the U.S…
Condition Summary: Trachoma; Chlamydia Infections
Full Story →
Des Plaines, Illinois – Abbott (NYSE: ABT) announced today it has received U.S. Food and Drug Administration (FDA) approval for the TECNIS® Multifocal 1-Piece intraocular lens (IOL) for cataract patients with and without presbyopia.
Diabetics suffering from a complication that can cause blindness can see better when treated with Roche’s eye drug Lucentis, giving the medicine a slight lift ahead of another keenly awaited trial.
The properties of optical stimuli need to be conveyed from the eye to the brain. To do this efficiently, the relevant information is extracted by pre-processing in the eye.